GlassScriptPhysician profile
Joseph V Ditrolio
NPI 1295767804
$4,579.24
in general payments reported to CMS, 2019-2025
26 companies · $940 in 2025
The $940 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $187 · 2021: $257 · 2022: $736 · 2023: $995 · 2024: $1,098 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,033.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $659.41 | 2022-2025 | |
| Boston Scientific Corporation | $380.99 | 2019-2025 | Lithovue |
| Janssen Biotech, INC. | $378.46 | 2019-2024 | Akeega, Erleada, Balversa |
| Ferring Pharmaceuticals INC. | $357.15 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $313.40 | 2023 | Myrisk |
| Astrazeneca Pharmaceuticals LP | $242.38 | 2024-2025 | Lynparza |
| Coloplast Corp | $158.41 | 2024-2025 | |
| Immunitybio, INC. | $153.85 | 2024 | |
| Olympus America INC. | $146.45 | 2025 | Itind System |
| Janssen Scientific Affairs, LLC | $144.66 | 2025 | Erleada |
| Axonics, INC. | $129.59 | 2023 | Axonics, Bulkamid |
| Baxter Healthcare | $125.00 | 2022 | |
| Pfizer INC. | $124.98 | 2019 | |
| Abbott Laboratories | $124.84 | 2025 | Freestyle Libre 3 |
| Procept Biorobotics Corporation | $123.23 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $120.75 | 2024 | |
| Photocure INC | $120.12 | 2022 | |
| Medtronic, INC. | $117.47 | 2023 | Interstim |
| Endo Pharmaceuticals INC. | $116.21 | 2023 | Xiaflex |
| Medtronic USA, INC. | $110.37 | 2020 | |
| Clarus Therapeutics INC. | $109.66 | 2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Urogen Pharma, INC. | $81.38 | 2024 | |
| Dornier Medtech America, INC | $77.11 | 2020 | |
| Urgo Medical North America, LLC | $39.44 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Myovant Sciences INC. | $23.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ditrolio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.